Central nervous system histoplasmosis in an immunocompetent patient.
Tai
Yen F
YF
Kullmann
Dimitri M
DM
Howard
Robin S
RS
Scott
Geoffrey M
GM
Hirsch
Nicholas P
NP
Revesz
Tamas
T
Leary
Siobhan M
SM
D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D020314:Central Nervous System Fungal Infections / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology*; D003951:Diagnostic Errors; D004825:Epiglottis / Q000382:microbiology / Q000473:pathology; D005260:Female; D006099:Granuloma / Q000382:microbiology / Q000473:pathology; D006660:Histoplasmosis / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D008875:Middle Aged; D012008:Recurrence; D013116:Spinal Cord / Q000382:microbiology / Q000473:pathology; D014390:Tuberculosis, Meningeal / Q000473:pathology / Q000503:physiopathology
D000935:Antifungal Agents; C068538:liposomal amphotericin B; D000666:Amphotericin B